other material
confidence high
sentiment negative
materiality 0.75
Lucid Diagnostics prices $25M public offering of 25M shares at $1.00 per share
Lucid Diagnostics Inc.
- Priced 25,000,000 shares of common stock at $1.00 per share; gross proceeds ~$25M before expenses.
- Underwriters granted 30-day option to purchase up to additional 3,750,000 shares at the same price.
- Net proceeds to be used for working capital and general corporate purposes; closing expected Sept 11, 2025.
- Canaccord Genuity and BTIG are joint bookrunners; Maxim Group is co-manager.
- Offering made under effective shelf registration statement S-3 (No. 333-268560).